Bharat Biotech to advance GSKs Shigella vaccine candidate
Bharat Biotech International Limited (BBIL) has entered into a licensing agreement with GSK plc to take over the development of altSonflex1‑2‑3, GSK’s promising Shigella vaccine candidate.
Get the latest news from world and India’s leading pharmaceutical companies Pharma Industry, pharmaceutical marketing, generic drugs, and Complete news for Pharmacy and Life Sciences professionals.